PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

Ann: ATL1103 Higher Dose Study-ANP.AX, page-14

  1. Akki
    35,746 Posts.
    lightbulb Created with Sketch. 554
    clock Created with Sketch.
    11/10/16
    14:21
    Post #: 19774385
    Good to see they finished the 3 patient study - now they just need to find that other $30M odd to get back in the clinic for a much larger phase IIb or phase III study.
    ANP Price at posting: 4.8¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
UNT UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $33.85K 424.8K

Buyers (Bids)

No. Vol. Price($)
3 76080 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 10226 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.